Literature DB >> 17434749

Purification of CK1 by affinity chromatography on immobilised axin.

Jens Reinhardt1, Yoan Ferandin, Laurent Meijer.   

Abstract

Members of the Casein Kinase 1 (CK1) family are implicated in the regulation of a variety of physiological processes like development and circadian rhythm, as well as in diseases like cancer and Alzheimer's disease. From that perspective, CK1 family members are interesting targets for potential chemotherapy. We describe here a rapid and efficient method for the purification of CK1 by affinity chromatography on an immobilised fragment of axin. Axin is a scaffolding protein that interacts with a multitude of proteins, amongst them APC, GSK-3, beta-catenin, CK1alpha, delta, and epsilon, and PP2A. A GST-tagged axin peptide (residues 495-684) was produced in Escherichia coli and either immobilised on glutathione agarose beads or purified and immobilised on CNBr-activated sepharose 4B. These "GST-axin" matrices were found to selectively bind native CK1alpha and CK1epsilon from porcine brain. The affinity-purified enzymes displayed high kinase activity. This single step purification method provides a convenient tool to efficiently purify large amounts of active native CK1 for screening purposes. This single step purification method also provides a convenient tool to follow the status of the axin-binding CK1 isoforms alpha, delta, and epsilon (protein levels, composition of isoforms, kinase activity) under different physiological settings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434749     DOI: 10.1016/j.pep.2007.02.020

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  21 in total

1.  Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus.

Authors:  Lilia Topol; Wen Chen; Hai Song; Timothy F Day; Yingzi Yang
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

2.  Roscovitine is a proteostasis regulator that corrects the trafficking defect of F508del-CFTR by a CDK-independent mechanism.

Authors:  C Norez; C Vandebrouck; J Bertrand; S Noel; E Durieu; N Oumata; H Galons; F Antigny; A Chatelier; P Bois; L Meijer; F Becq
Journal:  Br J Pharmacol       Date:  2014-11       Impact factor: 8.739

3.  From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity.

Authors:  Emilie Durieu; Eric Prina; Olivier Leclercq; Nassima Oumata; Nicolas Gaboriaud-Kolar; Konstantina Vougogiannopoulou; Nathalie Aulner; Audrey Defontaine; Joo Hwan No; Sandrine Ruchaud; Alexios-Leandros Skaltsounis; Hervé Galons; Gerald F Späth; Laurent Meijer; Najma Rachidi
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

4.  Analysis of binding interfaces of the human scaffold protein AXIN1 by peptide microarrays.

Authors:  Jakub Harnoš; Jan Ryneš; Pavlína Víšková; Silvie Foldynová-Trantírková; Lola Bajard-Ešner; Lukáš Trantírek; Vítězslav Bryja
Journal:  J Biol Chem       Date:  2018-08-30       Impact factor: 5.157

5.  Catalyst-free synthesis of quinazolin-4-ones from (hetero)aryl-guanidines: application to the synthesis of pyrazolo[4,3-f]quinazolin-9-ones, a new family of DYRK1A inhibitors.

Authors:  Julien Debray; Simon Bonte; Olivier Lozach; Laurent Meijer; Martine Demeunynck
Journal:  Mol Divers       Date:  2012-09-19       Impact factor: 2.943

6.  Casein kinase 1ε and 1α as novel players in polycystic kidney disease and mechanistic targets for (R)-roscovitine and (S)-CR8.

Authors:  Katy Billot; Charlène Coquil; Benoit Villiers; Béatrice Josselin-Foll; Nathalie Desban; Claire Delehouzé; Nassima Oumata; Yannick Le Meur; Alessandra Boletta; Thomas Weimbs; Melanie Grosch; Ralph Witzgall; Sophie Saunier; Evelyne Fischer; Marco Pontoglio; Alain Fautrel; Michal Mrug; Darren Wallace; Pamela V Tran; Marie Trudel; Nikolay Bukanov; Oxana Ibraghimov-Beskrovnaya; Laurent Meijer
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-14

7.  New 5-ylidene rhodanine derivatives based on the dispacamide A model.

Authors:  Solene Guiheneuf; Ludovic Paquin; François Carreaux; Emilie Durieu; Thierry Roisnel; Laurent Meijer; Jean-Pierre Bazureau
Journal:  Mol Divers       Date:  2014-03-02       Impact factor: 2.943

8.  Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection.

Authors:  Najma Rachidi; Jean François Taly; Emilie Durieu; Olivier Leclercq; Nathalie Aulner; Eric Prina; Pascale Pescher; Cedric Notredame; Laurent Meijer; Gerald F Späth
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

9.  Anticancer alkaloid lamellarins inhibit protein kinases.

Authors:  Dianne Baunbaek; Nolwenn Trinkler; Yoan Ferandin; Olivier Lozach; Poonsakdi Ploypradith; Somsak Rucirawat; Fumito Ishibashi; Masatomo Iwao; Laurent Meijer
Journal:  Mar Drugs       Date:  2008-10-07       Impact factor: 5.118

10.  Regulation of dynein-driven microtubule sliding by the axonemal protein kinase CK1 in Chlamydomonas flagella.

Authors:  Avanti Gokhale; Maureen Wirschell; Winfield S Sale
Journal:  J Cell Biol       Date:  2009-09-14       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.